The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-((1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyridin-3-yl)-1H-indole ID: ALA1085778
PubChem CID: 46891012
Max Phase: Preclinical
Molecular Formula: C19H20N4
Molecular Weight: 304.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2cccc3[nH]ccc23)cn1
Standard InChI: InChI=1S/C19H20N4/c1-22-11-15-9-14(22)12-23(15)19-6-5-13(10-21-19)16-3-2-4-18-17(16)7-8-20-18/h2-8,10,14-15,20H,9,11-12H2,1H3/t14-,15-/m0/s1
Standard InChI Key: CIUHWQDJGXODPO-GJZGRUSLSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
-4.7424 -14.7660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9278 -14.7660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5220 -14.0627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9278 -13.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7424 -13.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1552 -14.0627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7099 -14.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3030 -14.7713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4896 -14.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0774 -14.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4879 -13.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3034 -13.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9698 -14.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7488 -14.1997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7488 -12.5325 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.9342 -15.5806 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2519 -14.0657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9844 -13.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1594 -13.3521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4017 -14.0689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9920 -14.7880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1619 -14.7849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0976 -15.5734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5722 -16.0639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2456 -15.5785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
5 14 1 0
2 14 1 0
5 15 1 1
2 16 1 1
17 22 2 0
1 2 1 0
20 18 1 0
1 6 1 0
18 19 2 0
19 17 1 0
10 17 1 0
20 21 2 0
2 3 1 0
21 22 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.40Molecular Weight (Monoisotopic): 304.1688AlogP: 3.12#Rotatable Bonds: 2Polar Surface Area: 35.16Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.84CX LogP: 3.06CX LogD: 2.49Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.79Np Likeness Score: -0.42
References 1. Li T, Bunnelle WH, Ryther KB, Anderson DJ, Malysz J, Helfrich R, Grønlien JH, Håkerud M, Peters D, Schrimpf MR, Gopalakrishnan M, Ji J.. (2010) Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands., 20 (12): [PMID:20472430 ] [10.1016/j.bmcl.2010.04.105 ]